The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke.
暂无分享,去创建一个
E. Koroboki | G. Ntaios | K. Makaritsis | G Ntaios | A Vemmou | E Koroboki | P Savvari | K Makaritsis | M Saliaris | G Andrikopoulos | K Vemmos | P. Savvari | A. Vemmou | K. Vemmos | M. Saliaris | G. Andrikopoulos
[1] P. Sandercock,et al. Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial , 2001, Stroke.
[2] Á. Chamorro,et al. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. , 1999, Archives of neurology.
[3] J. Halperin,et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.
[4] T. N. t-P. S. S. Group,et al. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.
[5] M. Rosenqvist,et al. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). , 2007, European heart journal.
[6] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[7] S. Amitani,et al. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.
[8] A. Stępień,et al. Strokes in paroxysmal atrial fibrillation have more favorable outcome than in permanent atrial fibrillation , 2009, Acta neurologica Scandinavica.
[9] Salim Yusuf,et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. , 2007, Journal of the American College of Cardiology.
[10] Jeroen J. Bax,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] G. Lip. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? , 1997, The Lancet.
[12] P. Petersen,et al. Embolic complications in paroxysmal atrial fibrillation. , 1986, Stroke.
[13] Eso Writing,et al. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 , 2008 .
[14] S. Sacco,et al. Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study , 2005, Stroke.
[15] G. Ntaios,et al. Temporal Distribution and Magnitude of the Vulnerability Period around Stroke Depend on Stroke Subtype , 2011, Cerebrovascular Diseases.
[16] J. Lekakis,et al. The Athens Stroke Registry: Results of a Five-Year Hospital-Based Study , 2000, Cerebrovascular Diseases.
[17] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.